Breast Cancer Tissue Array of 150 Samples
      Home >> Welcome to Pantomics                                                                           Price List Download
 

Dedicated facility

 Catalog# BRC1502 - Human breast cancer tissue array

  
Lot# Cores Size Cut Format QA/QC Price
1Slide		 Price
Pack5
BRC150201 150 1.1mm 4um 10X15 H&E, IHC anti-Vimentin/Cytokeratin $150 $600
Order: sales@pantomics.com or call  1-415-863-2380, Form: Word or PDF; PDF data
 
 
Recommended applications: For Research use only. RNA or protein breast cancer/non-tumor tissue profiling using IHC or ISH; Antibody characterization.

Description: Breast cancer tissue array, 150 cores, non-overlapping with BRC1501 or BRC1503, including 75 cases of normal, reactive, premalignant and malignant (various grades and stages) tissues of the breast in duplicates. All the tissues were from surgical resection. They were fixed in 10% neutral buffered formalin for 24 hours and processed using identical SOPs. Sections were picked onto Superfrost Plus or APES coated Superfrost slides. They all have a guaranteed six months' shelf-life at 4C from the date of shipment. Each slide has >95% tissue core retention.
 
   

Array
position

Age

Sex

Histology

Grade

Stage (TNM)

AR

ER

PR

HER2

P53

EGFR

Ki67

A1,B1

47

F

Normal/hyperplasia

 

 

+, 2%

++, 10%

++~+++, 10%

-

-

+

+~++, 2%

A2,B2

40

F

Normal/hyperplasia

 

 

+, 2%

+~++, 5%

++, 10%

-

-

++

++, 5%

A3,B3

42

F

Normal/hyperplasia

 

 

-

+~++, 10%

++, 2%

-

-

++~+++

++, 5%

A4,B4

16

F

Fibroadenoma

 

 

+, 5%

++~+++, 50%

++~+++, 50%

-

-

-

-

A5,B5

50

F

Fibroadenoma

 

 

++, 5%

+++, 5%

+++, 10%

+

-

++

++, 2%

A6,B6

35

F

Invasive ductal carcinoma

II~III

T4N0M0

++~+++, 60%

+++, 90%

+~++, 30%

-

++, 2%

-

++, 20%

A7,B7

40

F

Invasive ductal carcinoma

III

T3N0M0

-

-

-

+++

-

-

++, 2%

A8,B8

53

F

Intraductal carcinoma

I

T3N0M0

++, 2%

-

-

+++

-

-

++, 2%

A9,B9

45

F

Invasive ductal carcinoma

I~II

T3N0M0

++, 5%

+++, 80%

+++, 70%

+~++

+~++, 2%

-

++, 2%

A10,B10

56

F

Invasive ductal carcinoma

II~III

T2N0M0

++, 10%

+++, 100%

++, 5%

+++

-

-

++, 15%

A11,B11

33

F

Invasive ductal carcinoma

II~III

T2N0M0

-

+, 10%

-

+-

-

+

+, 5%

A12,B12

37

F

Invasive ductal carcinoma

II~III

T3N2M0

-

+++, 50%

++, 20%

+

-

-

++, 5%

A13,B13

50

F

Invasive ductal carcinoma

II

T3N0M0

-

-

-

++~+++

++, 60%

-

++, 5%

A14,B14

64

F

Invasive tubulo-lobular carcinoma

II~III

T4N1M0

+, 5%

+++, 80%

+, 20%

-

+, 2%

-

+, 2%

A15,B15

44

F

Invasive ductal carcinoma

II~III

T3N1M0

++~+++, 50%

+~++, 10%

-

+++

-

-

++,10%

C1,D1

55

F

Invasive ductal carcinoma

II~III

T2N1M0

-

+, 5%

-

+++

+~++, 15%

-

+, 5%

C2,D2

47

F

Invasive ductal carcinoma

II~III

T2N0M0

-

-

-

+++

-

-

++, 15%

C3,D3

50

F

Invasive ductal carcinoma

II~III

T2N1M0

++, 5%

+++, 60%

+++, 50%

+

+, 2%

-

++, 5%

C4,D4

51

F

Invasive ductal carcinoma

II~III

T4N3Mx

-

++~+++, 50%

+, 10%

-

-

-

+~++, 2%

C5,D5

36

F

Invasive ductal carcinoma

II

T3N1M0

-

-

-

-

++, 15%

-

+~++, 5%

C6,D6

66

F

Invasive ductal carcinoma

II~III

T2N0M0

++, 5%

+++, 80%

+, 5%

+-

-

-

++, 5%

C7,D7

50

F

Invasive ductal carcinoma

II~III

T2N0M0

++, 10%

+++, 80%

++, 20%

-

-

-

++, 5%

C8,D8

66

F

Invasive ductal carcinoma

III

T2N1M0

+, 5%

+++, 80%

-

-

-

-

-

C9,D9

61

F

Invasive papillary carcinoma

I~II

T3N0M0

++, 20%

+++, 60%

+++, 50%

+~++

-

+++

++~+++, 5%

C10,D10

57

F

Invasive ductal carcinoma

II~III

T2N1M0

-

+++, 100%

++, 5%

+-

-

-

+, 2%

C11,D11

60

F

Invasive ductal carcinoma

II~III

T2N0M0

-

++~+++, 60%

-

-

-

-

++, 2%

C12,D12

56

F

Sarcoma

 

T2N0M0

-

-

-

-

++, 20%

++

+-

C13,D13

33

F

Ductal carcinoma in situ

I

TisN0M0

-

-

-

+++

+, 2%

+~++

+, 5%

C14,D14

40

F

Invasive ductal carcinoma

II

T4N2Mx

+, 5%

+, 5%

++~+++, 60%

+++

++, 30%

-

++, 15%

C15,D15

34

F

Ductal carcinoma in situ

I

TisN0M0

-

-

-

+++

++, 20%

-

++, 10%

E1,F1

40

F

Invasive ductal carcinoma

II

T2N0M0

+, 5%

-

-

+++

++, 50%

-

++~+++, 10%

E2,F2

50

F

Invasive ductal carcinoma

II~III

T2N0M0

+, 5%

-

-

+++

++, 2%

-

++~+++, 20%

E3,F3

44

F

Invasive ductal carcinoma

II

T2N0M0

-

-

-

-

++~+++, 50%

++*

++~+++, 50%

E4,F4

58

F

Invasive ductal carcinoma

II

T2N0M0

-

++~+++, 50%

+, 2%

+-

-

-

++~+++, 5%

E5,F5

37

F

Invasive ductal carcinoma

III

T4N1M0

-

-

-

-

+++, 95%

++*

++, 60%

E6,F6

61

F

Invasive ductal carcinoma

II~III

T4N0M0

+, 2%

+++, 60%

++, 20%

+

-

-

++, 5%

E7,F7

41

F

Invasive ductal carcinoma

I

T2N0M0

+, 2%

-

-

+++

+~++, 2%

-

++, 5%

E8,F8

28

F

Invasive ductal carcinoma

II

T2N0M0

+, 5%

+++, 80%

-

+

-

-

++, 5%

E9,F9

30

F

Invasive ductal carcinoma

II~III

T2N2M0

+, 5%

+, 30%

++, 10%

+++

++~+++, 60%

-

+++, 50%

E10,F10

52

F

Invasive ductal carcinoma

III

T2N0M0

-

-

-

-

-

+++*

+++, 80%

E11,F11

48

F

Invasive ductal carcinoma

III

T2N0M0

-

+++, 80%

+, 5%

+

+-

-

+++, 80%

E12,F12

43

F

Invasive ductal carcinoma

II

T2N2M0

+, 5%

++, 30%

-

+++

++, 15%

-

+++, 30%

E13,F13

46

F

Invasive ductal carcinoma

II~III

T2N0M0

-

-

-

++

-

+

++~+++, 60%

E14,F14

68

F

Invasive papillary carcinoma

I~II

T2N0M0

+~++, 50%

+++, 100%

+++, 80%

+

-

-

+++, 5%

E15,F15

49

F

Invasive ductal carcinoma

II~III

T2N0M0

-

-

-

-

-

-

++~+++, 10%

G1,H1

51

F

Invasive ductal carcinoma

II~III

T2N0M0

-

+, 10%

+~++, 5%

+++

-

-

++~+++, 60%

G2,H2

45

F

Invasive ductal carcinoma

II~III

T2N0M0

+, 5%

+++, 80%

-

+

-

-

++~+++, 50%

G3,H3

30

F

Invasive ductal carcinoma

III

T2N0M0

++~+++, 20%

++~+++, 80%

+++, 60%

-

+++*, 80%

++~+++

++~+++, 30%

G4,H4

54

F

Invasive ductal carcinoma

II

T2N0M0

++~+++, 30%

-

-

-

++, 20%

++*

+++, 5%

G5,H5

60

F

Invasive ductal carcinoma

II

T2N0M0

+, 2%

+++, 90%

+, 10%

-

-

-

+++, 5%

G6,H6

44

F

Invasive lobular carcinoma

II~III

T2N0M0

-

+, 60%

+++, 80%

-

-

-

++, 2%

G7,H7

38

F

Invasive ductal carcinoma

II~III

T2N2M0

-

++~+++, 80%

-

+-

-

-

+++, 20%

G8,H8

43

F

Invasive ductal carcinoma

II

T2N0M0

-

++, 60%

-

-

-

-

++, 2%

G9,H9

42

F

Invasive ductal carcinoma

II~III

T2N0M0

+, 5%

+~++, 50%

++, 60%

+

-

-

++~+++, 5%

G10,H10

55

F

Invasive ductal carcinoma

II

T2N0M0

-

-

-

+++

+~++, 20%

-

++~+++, 10%

G11,H11

49

F

Invasive ductal carcinoma

II~III

T2N0M0

++~+++, 80%

+++, 100%

+~++, 20%

+

-

-

++~+++, 15%

G12,H12

41

F

Invasive ductal carcinoma

I~II

T3N0M0

-

-

-

+++

-

-

++~+++, 20%

G13,H13

41

F

Colloid carcinoma

II

T3N0M0

+, 5%

++, 50%

++~+++, 15%

+

-

-

++~+++, 5%

G14,H14

41

F

Invasive ductal carcinoma

II~III

T2N0M0

-

-

-

+++

-

+~++

++~+++, 30%

G15,H15

46

F

Invasive ductal carcinoma

II~III

T4N0M0

-

++, 50%

-

-

-

-

++~+++, 5%

I1,J1

68

F

Invasive ductal carcinoma

II~III

T4N0M0

-

+++, 80%

++~+++, 20%

-

-

-

+++, 5%

I2,J2

49

F

Invasive ductal carcinoma

II~III

T2N0M0

+, 2%

++~+++, 80%

-

+

-

-

+++, 8%

I3,J3

55

F

Invasive ductal carcinoma

II

T2N0M0

+, 5%

+++, 100%

++~+++, 50%

-

+~++, 15%

-

+++, 8%

I4,J4

44

F

Invasive ductal carcinoma

II~III

T4N3Mx

-

-

-

+++

++, 15%

-

+++, 8%

I5,J5

60

F

Invasive ductal carcinoma

II

T2N0M0

-

-

-

+++

-

-

++~+++, 10%

I6,J6

43

F

Invasive ductal carcinoma

I~II

T3N0M0

+, 5%

++~+++, 60%

+++, 60%

-

-

-

++~+++, 2%

I7,J7

44

F

Invasive ductal carcinoma

II~III

T3N0M0

+, 2%

++~+++, 80%

++~+++, 50%

-

-

-

++~+++, 5%

I8,J8

42

F

Invasive ductal carcinoma

II~III

T4N2M0

+, 5%

++~+++, 60%

+~++, 20%

-

-

+

++, 5%

I9,J9

41

F

Invasive ductal carcinoma

II~III

T3N0M0

+, 2%

+, 20%

++, 50%

-

-

-

++, 5%

I10,J10

56

F

Invasive ductal carcinoma

II~III

T2N0M0

-

++~+++, 60%

+, 10%

-

-

-

+++, 30%

I11,J11

79

F

Invasive ductal carcinoma

II

T2N0M0

+, 20%

-

-

-

++, 20%

++~+++

++, 10%

I12,J12

57

F

Invasive ductal carcinoma

II

T3N0M0

+, 5%

-

-

+++

++, 2%

-

++, 5%

I13,J13

54

F

Invasive lobular carcinoma

III

T4N3M1

-

+++, 80%

-

-

+, 10%

-

+++, 10%

I14,J14

33

F

Invasive ductal carcinoma

II

T4N2M0

-

-

-

++~+++

-

-

++~+++, 10%

I15,J15

42

F

Invasive ductal carcinoma

II~III

T2N0M0

+~++, 5%

+,10%

+~++, 5%

++

-

-

++~+++, 10%

 

-------------------------------------------------------------------------------------------------
All Products | Ordering Information | Privacy Policy
Copyright © 2004-2005, Pantomics, Inc. 457 Mariposa Street, San Francisco, CA 94107, USA. Tel: 415-863-2380